干扰素通过干扰素抑制西奥菲林代谢
S J Williams1, J A Baird-Lambert, G C Farrell
1Department of Medicine, University of Sydney, NSW, Australia.
Lancet (London, England)
|October 24, 1987
概括
复合干扰素αA显著降低了慢性活性乙型肝炎患者和健康个体的理论清除. 这表明干扰素可能会影响药物代谢,并导致药物相互作用.
科学领域:
- 药理学 药理学是指药理学的学科.
- 肝病学 肝病学是一种肝病学.
- 免疫学 免疫学 免疫学
背景情况:
- 干扰素是具有多种生物效应的细胞因子,包括免疫调节.
- 肝脏药物代谢对于药物的有效性和安全性至关重要.
- 慢性活性乙型肝炎会影响肝功能和药物处理.
研究的目的:
- 为了研究复合人类干扰素αA对神素的药理动力学的影响.
- 探索干扰素作用与基线神素代谢之间的关系.
- 评估干扰素诱导药物相互作用的可能性.
主要方法:
- 一次肌肉内注射复合人体干扰素αA进行了注射.
- 测量了5名患有慢性活跃乙型肝炎的患者和4名健康对照者的西奥菲林清除和消除半衰期.
- 对比了治疗前和治疗后的药理动力学参数.
主要成果:
- 干扰素给药1天后,西奥菲林清除显著降低.
- 在干扰后,西奥菲林的消除半衰期显著增加.
- 干扰素的作用在具有快速代谢西奥菲林的个体中更为明显.
结论:
- 重组干扰素αA改变了神叶素的药理动力学,减少了其清除并增加了其半衰期.
- 内源性干扰素可能导致病毒感染或免疫接种期间观察到的肝脏药物代谢变化.
- 干扰素治疗存在临床显著药物相互作用的风险,特别是通过肝脏代谢的药物.
相关概念视频
Antiasthma Drugs: Methylxanthines
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Pharmacokinetics: Drug–Drug Interactions
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of many...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...


